Affinity Asset Advisors, LLC XBI Holdings History
Affinity Asset Advisors, LLC's SPDR Biotech ETF Holding Summary
As of 2025-03-31, Affinity Asset Advisors, LLC held 500,000.00 shares of SPDR Biotech ETF(XBI), totaling $40.55 Mil. This investment constitutes 4% of their stock portfolio, and Affinity Asset Advisors, LLC now holds 0.79% of the outstanding SPDR Biotech ETF(XBI) stock.
The initial trade took place in 2024Q2. And since then Affinity Asset Advisors, LLC has made 1 purchases of XBI, at an average price of $89.66, for a total of 37,550.00 shares. In addition, there have been 1 sales at an average price of $98.25 for 37,550.00 shares. Based on historical transaction data and XBI's current price of $84.88, Affinity Asset Advisors, LLC's estimated gain on his XBI holdings is $322,554.50, reflecting a 9.58% gain to date.
Affinity Asset Advisors, LLC XBI ($84.88) Holding Chart
Affinity Asset Advisors, LLC XBI ($84.88) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1